Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens

Pterostilbene, a Potential MCR-1 Inhibitor That Enhances the Efficacy of Polymyxin B

(2018) Yonglin Zhou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to polymyxins in Gram-negative organisms

(2017) Katy Jeannot et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Citrobacter braakii carrying plasmid-borne mcr-1 colistin resistance gene from ready-to-eat food from a market in the Chaco region of Bolivia

(2017) Samanta Sennati et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

(2017) J Nowak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Sirtuins as Novel Targets for Alzheimer's Disease and Other Neurodegenerative Disorders: Experimental and Genetic Evidence

(2017) Diego Albani et al.   JOURNAL OF ALZHEIMERS DISEASE

An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin

(2017) Antonio Cannatelli et al.   Scientific Reports

mcr-1.2, a NewmcrVariant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512

(2016) Vincenzo Di Pilato et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Detection of themcr-1Colistin Resistance Gene in Escherichia coli in Italy

(2016) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain

(2016) Tommaso Giani et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Agents of Last Resort

(2016) Keith S. Kaye et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis

(2016) Haggai Bar-Yoseph et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination?

(2016) Timothy Miles Rawson et al.   LANCET INFECTIOUS DISEASES

Multiplicity of effects and health benefits of resveratrol

(2016) Lolita Kuršvietienė et al.   Medicina-Lithuania

Multiplicity of effects and health benefits of resveratrol

(2016) Lolita Kuršvietienė et al.   Medicina-Lithuania

Polymyxin Resistance Caused bymgrBInactivation Is Not Associated with Significant Biological Cost in Klebsiella pneumoniae

(2015) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

(2015) David Brown   NATURE REVIEWS DRUG DISCOVERY

Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway

(2015) WEI LI et al.   ONCOLOGY REPORTS

Resveratrol antibacterial activity against Escherichia coli is mediated by Z-ring formation inhibition via suppression of FtsZ expression

(2015) Dahyun Hwang et al.   Scientific Reports

In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment

(2014) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin

(2014) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways

(2014) Bhupendra Singh et al.   CARCINOGENESIS

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014

(2014) M. Monaco et al.   Eurosurveillance

Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis

(2014) Laura J Sherrard et al.   LANCET

Studies of the in Vitro Antibacterial Activities of Several Polyphenols against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus

(2014) Yanli Su et al.   MOLECULES

In VivoEmergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoPmgrBRegulator

(2013) Antonio Cannatelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae

(2013) Carlo Tascini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence

(2013) Joao Tomé-Carneiro et al.   CURRENT PHARMACEUTICAL DESIGN

Selective Decontamination of the Digestive Tract in Gastrointestinal Surgery: Useful in Infection Prevention? A Systematic Review

(2013) Gabor S. A. Abis et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases

(2010) Albert Y. Sun et al.   MOLECULAR NEUROBIOLOGY

Characterization of pABVA01, a Plasmid Encoding the OXA-24 Carbapenemase from Italian Isolates of Acinetobacter baumannii

(2009) M. M. D'Andrea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY